Subcortical hyperintensities in Alzheimer's disease: No clear relationship with executive function and frontal perfusion on SPECT

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 5, 2007, Pages 380-388

  Levy Cooperman, Naama ^a,b,c   Lobaugh, Nancy J ^a,b   Caldwell, Curtis ^a,b   Gao, Fuqiang ^a   Black, Sandra E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; Cerebral perfusion; Executive function; Subcortical hyperintensities

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN PERFUSION; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DEMENTIA RATING SCALE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR ACTIVITY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL ANALOG SCALE;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ATROPHY; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 35648931045     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109570     Document Type: Article

References (54)

1. Braak H, Braak E: Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995;16:271-278.
2. Geula C: Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology 1998;51(1 suppl 1):S18-S29.
3. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, Bowen J, Teri L, Thompson J, Peskind ER, Raskind M, Larson EB: Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 1999;47:564-569.
4. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-175.
5. Erkinjuntti T: Subcortical ischemic vascular disease and dementia. Int Psychogeriatr 2003;15(suppl 1):23-26.
6. Sultzer DL, Chen ST, Brown CV, Mahler ME, Cummings JL, Hinkin CH, Mandelkern MA: Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. J Neuropsychiatry Clin Neurosci 2002;14:262-269.
7. Capizzano AA, Acion L, Bekinschtein T, Furman M, Gomila H, Martinez A, Mizrahi R, Starkstein SE: White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:822-827.
8. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI: The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
9. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995;26:1293-1301.
10. Sahlas DJ, Bilbao JM, Swartz RH, Black SE: Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol 2002;52:378-381.
11. Kalaria RN: Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002;13(suppl 2):48-52.
12. Gunning-Dixon FM, Raz N: The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224-232.
13. Pugh KG, Lipsitz LA: The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002;23:421-431.
14. Buckner RL: Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004;44:195-208.
15. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI: Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry 1996;60:158-167.
16. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ: White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-253.
17. Amar K, Bucks RS, Lewis T, Scott M, Wilcock GK: The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing 1996;25:443-448.
18. Van Heertum RL, Tikofsky RS: Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia. Semin Nucl Med 2003;33:77-85.
19. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ: Effects of white matter lesions and lacunes on cortical function. Arch Neurol 2004;61:1545-1550.
20. Ott BR, Faberman RS, Noto RB, Rogg JM, Hough TJ, Tung GA, Spencer PK: A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. Dement Geriatr Cogn Disord 1997;8:348-354.
21. Swartz RH, Sahlas DJ, Black SE: Strategic involvement of cholinergic pathways and executive dysfunction: does location of white matter signal hyperintensities matter? J Stroke Cerebrovasc Dis 2003;12:29-36.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. American Psychological Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychological Association, 1994.
24. Heaton RK: Wisconsin Card Sorting Test Manual. Odessa, Psychological Assessment Resources, 1981.
25. Spreen O, Strauss E: A Compendium of Neuropsychological Tests. New York, Oxford University Press, 1991.
26. Mattis S: Mental status examination for organic mental syndrome in the elderly patient; in Bellak L, Karasu TB (eds): Geriatric Psychiatry. New York, Grune & Stratton, 1976.
27. Chang LT: A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.
28. Lobaugh NJ, Caldwell CB, Black SE, Leibovitch FS, Swartz RH: Three brain SPECT region-of-interest templates in elderly people: normative values, hemispheric asymmetries, and a comparison of single- and multihead cameras. J Nucl Med 2000;41:45-56.
29. Pickut BA, Dierckx RA, Dobbeleir A, Audenaert K, Van LK, Vervaet A, De Deyn PP: Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 1999;90:103-112.
30. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ: Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994;21:503-508.
31. Callen DJ, Black SE, Caldwell CB: Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET. Eur J Nucl Med Mol Imaging 2002;29:899-906.
32. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A: The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-185.
33. Wardlaw JM, Ferguson KJ, Graham C: White matter hyperintensities and rating scales - Observer reliability varies with lesion load. J Neurol 2004;251:584-590.
34. Pantoni L, Simoni M, Pracucci G, Schmidt R, Barkhof F, Inzitari D: Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced? Stroke 2002;33:2827-2833.
35. Mantyla R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, Standertskjold-Nordenstam CG: Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke 1997;28:1614-1623.
36. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-1322.
37. de Leeuw FE, Barkhof F, Scheltens P: Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy? J Neurol Neurosurg Psychiatry 2005;76:1286-1288.
38. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
39. Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC: White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992;115:735-748.
40. Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE: A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke 2005;36:2126-2131.
41. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD: Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-920.
42. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, Reed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui H: Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-1635.
43. Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC: Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002;59:867-873.
44. Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust WJ, Weiner MW: Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord 2002;16:58-64.
45. Starkstein SE, Sabe L, Vazquez S, Teson A, Petracca G, Chemerinski E, Di Lorenzo G, Leiguarda R: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27:408-414.
46. Sabri O, Ringelstein EB, Hellwig D, Schneider R, Schreckenberger M, Kaiser HJ, Mull M, Buell U: Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999;30:556-566.
47. Herholz K, Heindel W, Rackl A, Neubauer I, Steinbrich W, Pietrzyk U, Erasmi-Korber H, Heiss WD: Regional cerebral blood flow in patients with leuko-araiosis and atherosclerotic carotid artery disease. Arch Neurol 1990;47:392-396.
48. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817.
49. Vermeer SE, Prins ND, den HT, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
50. O'Brien JT: Vascular cognitive impairment. Am J Geriatr Psychiatry 2006;14:724-733.
51. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P: The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
52. Lopez OL, Swihart AA, Becker JT, Reinmuth OM, Reynolds CF III, Rezek DL, Daly FL III: Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology 1990;40:1517-1522.
53. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, van Osch MJ, van der Grond J, van Buchem MA, Reiber JH: Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 2005;28:607-617.
54. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.